Monte Rosa Therapeutics, Inc. (GLUE) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US61225M1027
Monte Rosa Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 123.67 m USD |
| Operating income | -54.21 m USD |
| EBIT | -39.72 m USD |
| Net income | -38.63 m USD |
| Diluted EPS – continuing operations | -0.46 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of inflammatory diseases driven by IL-1a, IL-1ß and IL-18, as well as damage-associated molecular patterns. In addition, it develops CDK2 to treat multiple cancers, including ovarian, endometrial, gastric and breast. Further, its pipeline includes programs in immunology and inflammation indications, oncology, cardiovascular, metabolic, and genetic diseases. The company also develops QuEEN, a discovery engine, to enable its target-centric MGD discovery and development approach and its rational design of MGD product candidates. It has a strategic collaboration and licensing agreement with F. Hoffmann-La Roche Ltd.; and Novartis. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts.
More stocks
- Generation Development Group Ltd (GDG.AX)
- Terveystalo Oyj (TTALO.HE)
- ArcherMind Technology Nanjing Co Ltd (300598.SZ)
- Bafang Electric Suzhou Co Ltd (603489.SS)
- FIRST FINANCIAL CORP /IN/ (THFF)
- POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
- INVEX Controladora S.A.B. de C.V (INVEXA.MX)
- Beijing Tianma Intelligent Control Technology Co. Ltd. A (688570.SS)
- Voyageurs du Monde SA (ALVDM.PA)
- Chuzhou Duoli Automotive Technology Co. Ltd. A (001311.SZ)
- GoGold Resources Inc (GGD.TO)
- XiAn ChenXi Aviation Technology Corp Ltd (300581.SZ)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.